This was always going to be a packed out session (even at 5pm!): how we can use c-peptide measurements to improve the diagnosis of #diabetes
#DUKPC What's c-peptide? It's a molecule we make during the process of producing insulin. So it can be used to look at how much insulin you produce: people with #Type1diabetes have very very low c-peptide levels, while people with #Type2diabetes have higher levels.
#DUKPC

Really looking forward to this one: precision medicine. It’s all about tailoring treatments for the individual and moving away from a one size fits all approach. #dukpc .@markmccarthyoxf explains precision medicine could help us answers questions like:
Who is at greatest risk of #diabetes?
Who will respond best to different treatments?
Who will progress quickly or slowly?
#dukpc

We’re now switching gears to technology. The room is packed to the rafters as we hear from people with #diabetes who’ve made use of the tech available to build their own artificial pancreas, otherwise known as DIY looping. #dukpc DIY looping lets your CGM talk to your insulin pump. We think there are around 300 loopers in the UK. And they’re getting great results: more time in target and less hypos. #dukpc

Day 2 is off with a bang! @MaggieShepher13 has been awarded the Arnold Bloom lecture for her outstanding contributions to monogenic #diabetes care. She starts by thanking @DiabetesUK for supporting her right at the start of her career. #dukpc Monogenic diabetes are rare forms caused by a change in a single gene. Maggie realised these genetic types of #diabetes weren’t being diagnosed properly and made it her mission to change that. #dukpc

Fair to say #Type2diabetes has grabbed the limelight this morning, but now for some exciting updates on #Type1diabetes prevention
#dukpc Polly Bingley is up first to talk TrialNet - an international network of scientists dedicated to the prevention of #Type1diabetes.